Macrophage-specific overexpression of interleukin-5 attenuates atherosclerosis in LDL receptor-deficient mice.
W Zhao, T Lei, H Li, D Sun, X Mo, Z Wang, K Zhang, H Ou
文献索引:Gene Ther. 22 , 645-52, (2015)
全文:HTML全文
摘要
Interleukin-5 (IL-5) increases the secretion of natural T15/EO6 IgM antibodies that inhibit the uptake of oxidized low-density lipoprotein (LDL) by macrophages. This study aimed to determine whether macrophage-specific expression of IL-5 in LDL receptor-deficient mice (Ldlr(-/-)) could improve cholesterol metabolism and reduce atherosclerosis. To induce macrophage-specific IL-5 expression, the pLVCD68-IL5 lentivirus was delivered into Ldlr(-/-) mice via bone marrow transplantation. The recipient mice were fed a Western-type diet for 12 weeks to induce lesion formation. We found that IL-5 was efficiently and specifically overexpressed in macrophages in recipients of pLVCD68-IL5-transduced bone marrow cells (BMC). Plasma titers of T15/EO6 IgM antibodies were significantly elevated by 58% compared with control mice transplanted with pLVCD68 lacking the IL-5 coding sequence. Plaque areas of aortas in IL-5-overexpressing mice were reduced by 43% and associated with a 2.4-fold decrease in lesion size at the aortic roots when compared with mice receiving pLVCD68-transduced BMCs. The study showed that macrophage-specific overexpression of IL-5 inhibited the progression of atherosclerotic lesions. These findings suggest that modulation of IL-5 cytokine expression represents a potential strategy for intervention of familial hypercholesterolemia and other cardiovascular diseases.
相关化合物
相关文献:
2014-01-01
[Retrovirology 11 , 118, (2015)]
2014-01-01
[PLoS ONE 9(9) , e108055, (2014)]
2014-07-07
[Mol. Pharm. 11(7) , 1991-6, (2014)]
2015-02-01
[Cancer Chemother. Pharmacol. 75(2) , 431-7, (2015)]
2015-02-15
[Food Chem. 169 , 28-33, (2014)]